Effect of exposure of mosquito repellent green coil(Metofluthrin) among household families.

Post marketing surveillance study, among inmates of households exposed to 0.005% w/w Metofluthrin Green coil at five zones for a duration of one year. A prospective, non-comparative, multi-centre study in human volunteers.

Status

Active, not recruiting

Phases

Phase 4

Study type

Observational

Source

CTRI

Registry ID

CTRI/2017/08/009563

Enrollment

1600

Registered

2017-08-31

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: 0.005% w/w Metofluthrin Green coil: 0.005%w/w Green mosquito repellent coil Control Intervention1: NA: NA

Eligibility

Inclusion criteria

Inclusion criteria: (1) Written informed consent from the subject (2) Age more than 12 years completed

Exclusion criteria

Exclusion criteria: (1) Subjects with any condition which in the opinion of the investigator makes the subject unsuitable for inclusion. (2) Pregnancy (3) Lactation (4) Chronic respiratory disorder (5) Simultaneous Participation in any other trial

Design outcomes

Primary

Measure	Time frame
(1) Change from baseline in vital signs (2) Change from baseline in clinical chemistry, urine analysis and hematology (3) Adverse events reportingTimepoint: 0, 90, 180, 360 days.	—

Secondary

Measure	Time frame
NATimepoint: NA	—

Countries

India

Contacts

Public ContactDr Kedar Deobhankar

Ethicare Clinical Trial Services

milansatia@ethicare-cro.com9825585119

Outcome results